18-31598550-G-C

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000371.4(TTR):​c.337-18G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.045 in 1,612,924 control chromosomes in the GnomAD database, including 2,162 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.060 ( 370 hom., cov: 32)
Exomes 𝑓: 0.043 ( 1792 hom. )

Consequence

TTR
NM_000371.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:14

Conservation

PhyloP100: -0.503
Variant links:
Genes affected
TTR (HGNC:12405): (transthyretin) This gene encodes one of the three prealbumins, which include alpha-1-antitrypsin, transthyretin and orosomucoid. The encoded protein, transthyretin, is a homo-tetrameric carrier protein, which transports thyroid hormones in the plasma and cerebrospinal fluid. It is also involved in the transport of retinol (vitamin A) in the plasma by associating with retinol-binding protein. The protein may also be involved in other intracellular processes including proteolysis, nerve regeneration, autophagy and glucose homeostasis. Mutations in this gene are associated with amyloid deposition, predominantly affecting peripheral nerves or the heart, while a small percentage of the gene mutations are non-amyloidogenic. The mutations are implicated in the etiology of several diseases, including amyloidotic polyneuropathy, euthyroid hyperthyroxinaemia, amyloidotic vitreous opacities, cardiomyopathy, oculoleptomeningeal amyloidosis, meningocerebrovascular amyloidosis and carpal tunnel syndrome. [provided by RefSeq, Aug 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 18-31598550-G-C is Benign according to our data. Variant chr18-31598550-G-C is described in ClinVar as [Benign]. Clinvar id is 36892.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr18-31598550-G-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.1 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TTRNM_000371.4 linkc.337-18G>C intron_variant Intron 3 of 3 ENST00000237014.8 NP_000362.1 P02766E9KL36
LOC124904277XR_007066326.1 linkn.129-2855C>G intron_variant Intron 1 of 1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TTRENST00000237014.8 linkc.337-18G>C intron_variant Intron 3 of 3 1 NM_000371.4 ENSP00000237014.4 P02766
TTRENST00000649620.1 linkc.337-18G>C intron_variant Intron 5 of 5 ENSP00000497927.1 P02766
TTRENST00000610404.5 linkc.241-18G>C intron_variant Intron 3 of 3 5 ENSP00000477599.2 A0A087WT59

Frequencies

GnomAD3 genomes
AF:
0.0604
AC:
9168
AN:
151788
Hom.:
367
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0952
Gnomad AMI
AF:
0.0515
Gnomad AMR
AF:
0.104
Gnomad ASJ
AF:
0.0499
Gnomad EAS
AF:
0.0720
Gnomad SAS
AF:
0.0222
Gnomad FIN
AF:
0.0171
Gnomad MID
AF:
0.0665
Gnomad NFE
AF:
0.0389
Gnomad OTH
AF:
0.0581
GnomAD3 exomes
AF:
0.0572
AC:
14357
AN:
250802
Hom.:
696
AF XY:
0.0507
AC XY:
6878
AN XY:
135612
show subpopulations
Gnomad AFR exome
AF:
0.0969
Gnomad AMR exome
AF:
0.155
Gnomad ASJ exome
AF:
0.0551
Gnomad EAS exome
AF:
0.0740
Gnomad SAS exome
AF:
0.0212
Gnomad FIN exome
AF:
0.0194
Gnomad NFE exome
AF:
0.0366
Gnomad OTH exome
AF:
0.0477
GnomAD4 exome
AF:
0.0434
AC:
63455
AN:
1461026
Hom.:
1792
Cov.:
31
AF XY:
0.0421
AC XY:
30588
AN XY:
726838
show subpopulations
Gnomad4 AFR exome
AF:
0.0984
Gnomad4 AMR exome
AF:
0.149
Gnomad4 ASJ exome
AF:
0.0525
Gnomad4 EAS exome
AF:
0.0608
Gnomad4 SAS exome
AF:
0.0198
Gnomad4 FIN exome
AF:
0.0196
Gnomad4 NFE exome
AF:
0.0396
Gnomad4 OTH exome
AF:
0.0451
GnomAD4 genome
AF:
0.0604
AC:
9175
AN:
151898
Hom.:
370
Cov.:
32
AF XY:
0.0590
AC XY:
4384
AN XY:
74268
show subpopulations
Gnomad4 AFR
AF:
0.0949
Gnomad4 AMR
AF:
0.104
Gnomad4 ASJ
AF:
0.0499
Gnomad4 EAS
AF:
0.0722
Gnomad4 SAS
AF:
0.0222
Gnomad4 FIN
AF:
0.0171
Gnomad4 NFE
AF:
0.0389
Gnomad4 OTH
AF:
0.0575
Alfa
AF:
0.0201
Hom.:
13
Bravo
AF:
0.0706

ClinVar

Significance: Benign
Submissions summary: Benign:14
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Jul 06, 2015
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Apr 04, 2016
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

May 23, 2022
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Mar 03, 2015
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Cardiomyopathy Benign:2
Sep 29, 2022
Cohesion Phenomics
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Aug 18, 2011
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing;curation

- -

Charcot-Marie-Tooth disease Benign:1
-
Molecular Genetics Laboratory, London Health Sciences Centre
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Cardiovascular phenotype Benign:1
Sep 06, 2017
Ambry Genetics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Amyloidosis, hereditary systemic 1 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
0.29
DANN
Benign
0.59

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs36204272; hg19: chr18-29178513; COSMIC: COSV52701947; COSMIC: COSV52701947; API